咽癌治疗前18F-FDG PET肿瘤纹理特征与基因表达的相关性及其对放疗为基础治疗结局的意义
回顾性分析57例III-IV期口咽或下咽癌患者,研究治疗前18F-FDG PET-CT肿瘤纹理特征与活检标本免疫组化基因表达的相关性,并分析纹理特征对放疗为基础治疗结局的预后价值。VEGF过表达与GLNUz和RLNU升高正相关;晚期T分期、VEGF免疫反应评分>2及较高GLNUz是病因特异性生存差的预后因素。
要点
- VEGF过表达与矩阵异质性指标GLNUz和RLNU升高呈正相关。
- 晚期T分期(p=0.01,HR=3.38)、VEGF评分>2(p=0.03,HR=2.79)、较高GLNUz(p=0.04,HR=2.51)为病因特异性生存差的预后因素。
- 晚期T分期、HIF-1α染色百分比≥80%及较高GLNUz为原发灶无复发生存差的预后因素。
核心结论
- VEGF过表达与矩阵指标GLNUz和RLNU升高相关。
- 对于需要放疗的咽癌患者,治疗结局可根据纹理特征、T分期和生物标志物进行分层。
研究设计与样本
- 回顾性分析57例已完成根治性治疗的III-IV期口咽或下咽癌患者的记录。
- 研究四组纹理特征及31项指标,并分析治疗前活检标本的免疫组化数据(Glut1、CAIX、VEGF、HIF-1α、EGFR、Ki-67、Bcl-2、CLAUDIN-4、YAP-1、c-Met和p16)。
- 分析指标与基因组表达的关系,以及各种纹理特征相对于病因特异性生存和原发灶无复发生存的稳健性。
主要发现
- VEGF过表达与基于区域灰度非均匀性(GLNUz)和游程长度非均匀性(RLNU)获得的矩阵异质性值升高呈正相关。
- 晚期T分期(p=0.01,HR=3.38)、VEGF免疫反应评分>2(p=0.03,HR=2.79)和较高GLNUz值(p=0.04,HR=2.51)是病因特异性生存低的预后因素。
- 晚期T分期、HIF-1α染色百分比≥80%和较高GLNUz值是原发灶无复发生存低的预后因素。
关键数值与推荐
- VEGF免疫反应评分>2(p=0.03,HR=2.79)与病因特异性生存低相关。
- 较高GLNUz值(p=0.04,HR=2.51)与病因特异性生存低相关。
- 晚期T分期(p=0.01,HR=3.38)与病因特异性生存低相关。
- HIF-1α染色百分比≥80%与原发性无复发生存低相关。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study investigated the correlation of the matrix heterogeneity of tumors on 18F-fluorodeoxyglucose positron emission tomography-computed tomography (PET-CT) with gene-expression profiling in patients with pharyngeal cancer and determined the prognostic factors for radiotherapy-based treatment outcomes. METHODS: We retrospectively reviewed the records of 57 patients with stage III-IV oropharyngeal or hypopharyngeal cancer who had completed definitive therapy. Four groups of the textural features as well as 31 indices were studied in addition to maximum standard uptake value, metastatic tumor volume, and total lesion glycolysis. Immunohistochemical data from pretreatment biopsy specimens (Glut1, CAIX, VEGF, HIF-1α, EGFR, Ki-67, Bcl-2, CLAUDIN-4, YAP-1, c-Met, and p16) were analyzed. The relationships between the indices and genomic expression were studied, and the robustness of various textural features relative to cause-specific survival and primary relapse-free survival was analyzed. RESULTS: The overexpression of VEGF was positively associated with the increased values of the matrix heterogeneity obtained using gray-level nonuniformity for zone (GLNUz) and run-length nonuniformity (RLNU). Advanced T stage (p = 0.01, hazard ratio [HR] = 3.38), a VEGF immunoreactive score of >2 (p = 0.03, HR = 2.79), and a higher GLNUz value (p = 0.04, HR = 2.51) were prognostic factors for low cause-specific survival, whereas advanced T stage, a HIF-1α staining percentage of ≥80%, and a higher GLNUz value were prognostic factors for low primary-relapse free survival. CONCLUSIONS: The overexpression of VEGF was associated with the increased matrix index of GLNUz and RLNU. For patients with pharyngeal cancer requiring radiotherapy, the treatment outcome can be stratified according to the textural features, T stage, and biomarkers.
引用
- Chen SW, Shen WC, Lin YC, et al. Correlation of pretreatment 18F-FDG PET tumor textural features with gene expression in pharyngeal cancer and implications for radiotherapy-based treatment outcomes. Eur J Nucl Med Mol Imaging. 2016. PMID: 27999896. doi:10.1007/s00259-016-3580-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。